Magnetic resonance imaging of the knee: A tool for prediction of joint damage in early rheumatoid arthritis?

Scandinavian Journal of Rheumatology

Volumn 33, Issue 3, 2004, Pages 154-161

  Forslind, K ^a,d   Larsson, E M ^c   Eberhardt, K ^c   Johansson, A ^b   Svensson, B ^a  

^a Rheumatology Section   (Sweden)

^b Centre for Diagnostics   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d Section of Rheumatology   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; METHOTREXATE; PREDNISOLONE; PRORECID; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; STEROID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE EROSION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DISEASE ACTIVITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; JOINT DESTRUCTION; KNEE ARTHRITIS; KNEE RADIOGRAPHY; LOGISTIC REGRESSION ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYNOVITIS;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; FEMALE; HEALTH STATUS; HUMANS; INFLAMMATION; JOINT DISEASES; KNEE JOINT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHYSICAL EXAMINATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SYNOVITIS;

EID: 2942511257     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740410006862     Document Type: Article

References (40)

1. Jacobsen EA, Riise T. MRI of cervical spine with flexion and extension used in patients with rheumatoid arthritis. Scand J Rheumatol 2000;29:249-54.
2. Klarlund M, Ostergaard M, Rostrup E, Skjödt H, Lorenzen Ib. Dynamic magnetic resonance imaging of the metacarpophalangeal joints in rheumatoid arthritis, early unclassified polyarthritis, and healthy controls. Scand J Rheumatol 2000;29:108-15.
3. Kursunoglu-Brahme S, Riccio T, Weisman MH, Resnick D, Zvaifler N, Sanders ME, Fix C. Rheumatoid knee: role of gadopentetate-enhanced MR imaging. Radiology 1990;176: 831-5.
4. Adam G, Dammer M, Bohndorf K, Christoph R, Fenke F, Günther RW. Rheumatoid arthritis of the knee: value of gadopentetate dimeglumine-enhanced MR imaging. Am J Rheumatol 1991;156:125-9.
5. Hervé-Somma CMP, Sebbag GH, Prieur A-M, Bonnerot V, Lallemand DP. Juvenile rheumatoid arthritis of the knee: MR evaluation with Gd-DOTA. Radiology 1992;182:93-8.
6. König H, Sieper J, Wolf K-J. Rheumatoid arthritis: evaluation of hypervascular and fibrous pannus with dynamic MR imaging enhanced with Gd-DTPA. Radiology 1990;176: 473-7.
7. Björkengren AG, Geborek P, Rydholm U, Holtås S, Petterson H. MR imaging of the knee in acute rheumatoid arthritis: synovial uptake of gadolinium-DOTA. Am J Radiol 1990;155: 329-32.
8. Ostergaard M, Gideon P, Henriksen O, Lorenzen I. Synovial volume - a marker of disease severity in rheumatoid arthritis? Quantification by MRI. Scand J Rheumatol 1994; 23:197-202.
9. Ostergaard M, Hansen M, Stoltenberg M, Gideon P, Klarlund M, Jensen KE, Lorenzen I. Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis. Arthritis Rheum 1999;42:918-29.
10. Veal DJ, Reece RJ, Parson W, Radjenovic A, O'Connor PJ, Orgles CS, et al. Intra-articular primatised anti-CD4: efficacy in resistant rheumatoid knees. A study of combined arthroscopy, magnetic resonance imaging, and histology. Ann Rheum Dis 1999;58:342-9.
11. Peterfy CG. Magnetic resonance imaging in rheumatoid arthritis. Current status and future directions (OMERACT) J Rheumatol 2001;28:1134-42.
12. Conaghan PG, Quinn MA, O'Connor P, Wakefield RJ, Karim Z, Emery P. Can very high-dose anti-tumor necrosis factor blockade at onset of rheumatoid arthritis produce long-term remission? [Letter] Arthritis Rheum 2002;46:1971-2.
13. Reece RJ, Kraan MC, Radjenovic A, Veale DJ, O'Connor PJ, Ridgway JP, et al. Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging. Arthritis Rheum 2002;46:366-72.
14. Foley-Nolan D, Stack JP, Ryan M, Redmond U, Barry C, Ennis J, et al. Magnetic resonance imaging in the assessment of rheumatoid arthritis: a comparison with plain film radiographs. Br J Rheumatol 1991;30:101-6.
15. Ostergaard M, Gideon P, Sorensen K, Hansen M, Stoltenberg M, Henriksen O, et al. Scoring of synovitis membrane hypertrophy and bone erosions by MR imaging in clinically active and inactive rheumatoid arthritis of the wrist. Scand J Rheumatol 1995;24:212-8.
16. McQueen FM, Stewart N, Crabbe J, Robinson E, Yeoman S, Tan PLJ, et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom-onset. Ann Rheum Dis 1998;57:350-6.
17. McQueen FM, Stewart N, Crabbe J, Robinson E, Yeoman S, Tan PLJ, et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement. Ann Rheum Dis 1999;58:156-63.
18. Backhaus M, Kamradt T, Sandrock D, Loreck D, Fritz J, Wolf J, et al. Arthritis of the finger joints. A comprehensive approach comparing conventional radiography, scintigraphy, ultrasound and contrast-enhanced magnetic resonance imaging. Arthritis Rheum 1999;42:1232-45.
19. Forslind K, Larsson EM, Johanson Å, Svensson B. Detection of joint pathology by magnetic resonance imaging in patients with early rheumatoid arthritis. Br J Rheumatol 1997;36: 683-8.
20. Svensson B, Schauffelberger C, Teleman A, Theander J [for the BARFOT study group]. Remission and response to early treatment of rheumatoid arthritis assessed by the Disease Activity Score. Rheumatology 2000;39:1031-6.
21. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
22. Boegård T, Johansson Å, Rudling O, Pettersson I, Forslind K, Jonsson K. Gadolinium-DTPA-enhanced MR imaging in asymptomatic knees. Acta Radiol 1996;37:877-82.
23. Conaghan P, Edmonds J, Emery P, Genant H, Gibbon W, Klarlund M, et al. Magnetic resonance imaging in rheumatoid arthritis: summary of OMERACT activities, current status, and plans. J Rheumatol 2001;28:1158-61.
24. Van der Heijde DMFM, van't Hof MA, van Riel PLCM, van Leeuwen MA, van Rijswik MH, van de Putte LBA. Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis 1992;51:177-81.
25. Prevoo M, van't Hof M, Kuper H, van Leeuven A, van de Putte L, van Riel P. Modified disease activity scores that include twenty-eight joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;39:44-8.
26. Ekdahl C, Eberhardt K, Andersson I, Svensson B. Assessing disability in patients with rheumatoid arthritis. Scand J Rheumatol 1988;17:263-71.
27. Fries JF, Spit P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23: 137-45.
28. Huang J, Stewart N, Crabbe J, Robinson E, McLean L, Yeoman S, et al. A 1-year follow-up study of dynamic magnetic resonance imaging in early rheumatoid arthritis reveals synovitis to be increased in shared epitope-positive patients and predictive of erosions at 1 year. Rheumatology 2000;39:407-16.
29. McQueen FM, Benton N, Crabbe J, Robinson E, Yeoman S, McLean L, Stewart N. What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using X-rays and magnetic resonance imaging over the first two years of disease. Ann Rheum Dis 2001;60:859-68.
30. Ostergaard M, Hansen M, Stoltenberg M, Jensen KE, Szkudlarek M, Pedersen-Zbinden B, Lorenzen I. New radiographic bone erosions in the wrists of patients with rheumatoid arthritis are detectable with magnetic resonance imaging a median of two years earlier. Arthritis Rheum 2003;48:2128-31.
31. McGonagle D, Green MJ, Proudman S, Richardson C, Veale D, O'Connor P, et al. The majority of patients with rheumatoid arthritis have erosive disease at presentation when magnetic resonance imaging of the dominant hand is employed. Br J Rheumatol 1997;36 Suppl 1:121.
32. Kirwan JR. The relationship between synovitis and erosions in rheumatoid arthritis. Br J Rheum 1997;36:225-8.
33. McGonagle D, Conaghan PG, O'Connor P, Gibbon W, Green M, Wakefield R, et al. The relationship between synovitis and bone changes in early rheumatoid arthritis. A controlled magnetic resonance imaging study. Arthritis Rheum 1999;42:1706-11.
34. Ostergaard M, Stoltenberg M, Lövgreen-Nielsen P, Volck B, Sonne-Holm S, Lorenzen I. Quantification of synovitis by MRI: Correlation between dynamic and static gadolinium-enhanched magnetic resonance imaging and microscopic and macroscopic signs of synovial inflammation. Magn Reson Imaging 1998;16:743-54.
35. Ostergaard M, Szkudlarek M. Imaging in rheumatoid arthritis - why MRI and ultrasonography can no longer be ignored [review]. Scand J Rheumatol 2003;32:63-73.
36. McQueen FM, Benton N, Perry D, Crabbe J, Robinson E, Yeoman S, et al. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum 2003;48:1814-27.
37. Jalava S, Reunanen K. Healing of erosions in rheumatoid arthritis. Scand J Rheumatol 1982;11:97-100.
38. Rau R, Herborn G. Healing phenomenon of erosive changes in rheumatoid arthritis patients undergoing disease-modifying antirheumatic drug therapy. Arthritis Rheum 1996;39:162-8.
39. Rau R, Wassenberg S, Herborn G, Perschel WL, Freitag G. Identification of radiologie healing phenomena in patients with rheumatoid arthritis. J Rheumatol 2001;28:2608-15.
40. Forslind K, Johansson Å, Larsson E-M, Svensson B. Magnetic resonance imaging of the fifth metatarsophalangeal joint compared with conventional radiography in patients with early rheumatoid arthritis. Scand J Rheumatol 2003;32:131-7.